CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 26 enrolled
Drug / intervention
Chlordiazepoxide +1 moredrug
Likely dose
Chlordiazepoxide 25mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01573052
NCT01573052Phase 4Completed
CompareCT.gov

Comparison of Chlordiazepoxide and Gabapentin for Outpatient Alcohol Detoxification Treatment

VA Salt Lake City Health Care System·interventional·Posted Apr 6, 2012·Updated Aug 17, 2020

In Brief

A Phase 4 clinical trial evaluating Chlordiazepoxide and Gabapentin for Alcohol Withdrawal. Completed, enrolled 26 participants across 1 site.

Detailed Summary

A randomized, double-blind controlled trial comparing treatment outcomes between chlordiazepoxide, or gabapentin to treat alcohol withdrawal syndrome in alcohol dependent veteran subjects. The objective of this trial is to compare the safety and effectiveness of these two medications. Intervention is a fixed dose taper of chlordiazepoxide, or gabapentin over 6 days. Subjects will be evaluated for 7-10 days to monitor alcohol abstinence, withdrawal severity scores, adverse events including ataxia, sedation, cognitive function and alcohol craving.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Withdrawal
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 6, 2012
Enrollment StartMar 1, 2004
Primary CompletionAug 1, 2010
Study CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 14.2 years ago

Interventions

Chlordiazepoxidedrug

25mg four times daily x 3 days then tapered over 3 days

Gabapentindrug

300mg four times daily x 3 days then tapered over 3 days